Key Updates
XP Inc shares have staged a sharp recovery, up 5.95% since the last report to $18.15, a clear reversal after a string of declines. Wall Street analysts see 32.2% upside based on the average price target, pointing to significant undervaluation at current levels. This bounce breaks the downtrend seen in prior reports.
Current Trend
XP Inc is in a short-term recovery phase after a pullback. The stock rose 2.20% over the past day, showing positive momentum. Monthly return is +3.30%, suggesting the trend is stabilizing. However, the six-month move is still down 2.63%, reflecting ongoing structural challenges. The 1.63% drop over five days has been offset by the current rally.
Investment Thesis
The XP Inc thesis rests on the company's leading position in financial services and digital brokerage in Brazil. It continues to expand its product ecosystem and grow its client base. Strong Q3 2025 results and an expanded share buyback program, noted in earlier reports, support the long-term growth outlook.
Thesis Status
The thesis has improved thanks to the sharp rebound in the stock and optimistic analyst forecasts. The 32.2% upside per Wall Street estimates suggests the market is underpricing the company's fundamental value. At $18.15, the stock offers an attractive entry point for long-term investors, especially given the strong operating results posted earlier.
Key Drivers
The main catalyst for the current rally is upbeat Wall Street analyst commentary, which sees 32.2% upside from current levels. According to a Zacks analysis, the average analyst price target sits well above the current market price, fueling positive sentiment among investors. That sets a favorable backdrop for further recovery.
Technical Picture
Technically, XP Inc is showing signs of a trend reversal at $18.15. The 5.95% gain since the last report breaks the sequence of declines seen in prior periods. The 2.20% daily advance confirms near-term buying strength. Resistance sits at $18.50; a break above that level could open the door to further upside toward analyst targets.
Bull Case
- 32.2% upside per Wall Street estimates points to significant undervaluation (Zacks)
- Strong Q3 2025 results, noted in earlier reports, provide a fundamental base for growth
- Expanded share buyback program supports the stock and signals management confidence
- The 5.95% rebound breaks the downtrend and builds a technical foundation for further gains
- Monthly return of +3.30% shows stabilization and the start of a recovery trend
Bear Case
- Six-month performance is still negative at -2.63%, pointing to structural challenges
- The 1.63% five-day decline shows lingering volatility and uncertainty
- Prior reports logged a series of declines, which could signal weak fundamentals
- High analyst expectations (+32.2%) create disappointment risk if forecasts are missed
- Macro risks in the Brazilian market could weigh on the company's operating results